If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive ...
A new study could lead to more widespread use of imaging technique to improve survival and prevent complications. Using intravascular imaging (IVI) to guide stent implantation during complex stenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback